Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies - Reply

被引：0

作者：

Roehrborn, CG ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75230 USA

来源：

BJU INTERNATIONAL | 2003年 / 92卷 / 09期

关键词：

D O I：

10.1111/j.1464-410X.2003.4537b.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1044 / 1045

页数：2

共 50 条

[21] Editorial Comment to Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea
Akino, Hironobu
INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (07) : 676 - 676
[22] Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial
M I Resnick
C G Roehrborn
Prostate Cancer and Prostatic Diseases, 2007, 10 : 155 - 159
[23] Effect of doxazosin on the symptoms of benign prostatic hyperplasia: Results from three double-blind placebo-controlled studies
Mobley, DF
Kaplan, S
Ice, K
Gaffney, M
Dias, N
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1997, 51 (05) : 282 - 288
[24] Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial
Pinggera, Germar-Michael
Frauscher, Ferdinand
Paduch, Darius A.
Bolyakov, Alex
Efros, Mitchell
Kaminetsky, Jed
Da Pozzo, Luigi
Esler, Anne
Cox, David
UROLOGY, 2014, 84 (02) : 412 - 419
[25] Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study
Zhang, Zhichao
Li, Hanzhong
Zhang, Xiaodong
Dai, Yutian
Park, Hyun Jun
Jiann, Bang-Ping
Li, Peng
Lou, Ying
Ye, Zhangqun
Viktrup, Lars
INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (02) : 192 - 200
[26] Urodynamic effects of doxazosin in men with lower urinary tract symptoms and benign prostatic obstruction - Results from three double-blind placebo-controlled studies
Abrams, P
EUROPEAN UROLOGY, 1997, 32 (01) : 39 - 46
[27] Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study - Editorial comment
Djavan, B
Fong, YK
UROLOGY, 2005, 65 (01) : 89 - 90
[28] Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies (vol 82, pg 667, 2013)
Porst, H.
Oelke, M.
Goldfischer, E. R.
Cox, D.
Watts, S.
Dey, D.
UROLOGY, 2014, 83 (03) : 684 - 684
[29] Postvoid residual urine in patients with lower urinary tract symptoms succestive of benign prostatic hyperplasia: Pooled analysis of eleven controlled studies with alfuzosin
McNeill, SA
Hargreave, TB
Geffriaud-Ricouard, C
Santoni, JP
Roehrborn, CG
UROLOGY, 2001, 57 (03) : 459 - 465
[30] The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
Lee, Sung Won
Paick, Jae Seung
Park, Hyun Jun
Won, Ji Eon
Morisaki, Yoji
Sorsaburu, Sebastian
Viktrup, Lars
WORLD JOURNAL OF MENS HEALTH, 2014, 32 (01): : 28 - 35

← 1 2 3 4 5 →